DNA sequencing by mass spectrometry via exonuclease degradation

• US 6,140,053 A
• Filed: 09/25/1998
• Issued: 10/31/2000
• Est. Priority Date: 11/06/1996
• Status: Expired due to Term

• Current Assignee: Agena Bioscience Inc. (Mesa Laboratories Inc.)
• Original Assignee: Sequenom Incorporated (Laboratory Corporation Of America Holdings)
• Inventors: Koster, Hubert
• Primary Examiner(s): Marschel, Ardin H.
• Application Number:
  US09/160,671
• Time in Patent Office: 767 Days
• Field of Search: 435/6, 536/25.3, 422/68.1
• US Class Current: 435/5
• CPC Class Codes: C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
• CPC Class Codes: C12Q 1/6858 Allele-specific amplification
• CPC Class Codes: C12Q 1/6872 involving mass spectrometry
• CPC Class Codes: G01N 35/1067 for transfer to or from containers having different spacing

Abstract

The invention provides fast and highly accurate mass spectrometer based processes for directly sequencing a target nucleic acid (or fragments generated from the target nucleic acid), which by means of protection, specificity of enzymatic activity, or immobilization, are unilaterally degraded in a stepwise manner via exonuclease digestion and the nucleotides, derivatives or truncated sequences detected by mass spectrometry.

Claims

1. A method of determining a sequence of a nucleic acid, comprising the steps of:

(i) obtaining the nucleic acid to be sequenced;

(ii) cleaving the nucleic acid to be sequenced from a first end to a second end with an exonuclease to sequentially release individual nucleotides;

(iii) identifying each of the sequentially released nucleotides by mass spectrometry; and

(iv) determining the sequence of the nucleic acid from the identified nucleotides.

2. The method of claim 1, wherein the nucleic acid is a 2'"'"'-deoxyribonucleic acid (DNA).

3. The method of claim 1, wherein the nucleic acid is a ribonucleic acid (RNA).

4. The method of claim 1, wherein the exonuclease is selected from the group consisting of snake venom phosphodiesterase, spleen phosphodiesterase, Bal-31 nuclease, E. coli exonuclease I, E. coli exonuclease VII, Mung Bean Nuclease, S1 Nuclease, an exonuclease activity of E. coli DNA polymerase I, an exonuclease activity of the Klenow fragment of DNA polymerase I, an exonuclease activity of T4 DNA polymerase, an exonuclease activity of T7 DNA polymerase and an exonuclease activity of Taq DNA polymerase, E. coli exonuclease III, λ

exonuclease an exonuclease activity of Pyrococcus species GB-D DNA polymerase and an exonuclease activity of Thermococcus litoralis DNA polymerase.

5. The method according to claim 1, wherein the exonuclease is immobilized by covalent attachment to a solid support, entrapment within a gel matrix, or contained in a reactor with a semipermeable membrane.

6. The method according to claim 5, wherein the solid support is a capillary and the exonuclease is covalently attached to an inner wall of the capillary.

7. The method of claim 5, wherein the solid support is selected from the group consisting of glass beads, cellulose beads, polystyrene beads, epichlorohydrin-cross-linked -dextran beads, polyacrylamide beads and agarose beads.

8. The method according to claim 5, wherein the solid support is a flat membrane.

9. The method according to claim 1, wherein the nucleic acid is immobilized by covalent attachment to a solid support and the exonuclease is in a solution and is contacted with the immobilized nucleic acid.

10. The method according to claim 9, wherein the solid support is a capillary and the nucleic acid is covalently attached to an inner wall of the capillary.

11. The method according to claim 9, wherein the solid support is selected from the group consisting of glass beads, cellulose beads, polystyrene beads, epichlorohydrin-cross-linked dextran beads, polyacrylamide beads and agarose beads.

12. The method according to claim 9, wherein the solid support is a flat membrane.

13. The method according to claim 1, wherein the nucleic acid comprises mass-modified nucleotides.

14. The method according to claim 13, wherein the mass-modified nucleotides modulate the rate of the exonuclease activity.

15. The method according to claim 1, wherein the sequentially released nucleotides are mass-modified subsequent to exonuclease release and prior to mass spectrometric identification.

16. The method according to claim 15, wherein the sequentially released nucleotides are mass-modified by contact with an alkaline phosphatase.

17. The method of claim 9, wherein the nucleic acid further comprises a linking group (L) for covalently attaching the nucleic acid to the solid support.

18. The method of claim 17, wherein the solid support further comprises a splint oligonucleotide and the linking group (L) comprises a nucleotide sequence able to anneal to the splint oligonucleotide and be covalently attached to the solid support by action of a ligase.

19. The method of claim 1, wherein the mass spectrometry format used in step (iii) is selected from the group consisting of fast atomic bombardment (FAB), plasma desorption (PD), thermospray (TS), electrospray (ES) and matrix assisted laser desorption (MALDI).

20. The method of claim 1, wherein the mass analyzer used in step (iii) is a time-of-flight (TOF) configuration or a quadrapole.

21. A method of determining a sequence of a nucleic acid, comprising the steps of:

(i) obtaining the nucleic acid to be sequenced;

(ii) cleaving the nucleic acid to be sequenced from a first end to a second end with an exonuclease to produce multiple sets of nested nucleic acid fragments;

(iii) determining the molecular weight value of each one of the sets of nucleic acid fragments by mass spectrometry; and

(iv) determining the sequence of the nucleic acid from the molecular weight values of the sets of nucleic acid fragments.

22. The method of claim 21, wherein the nucleic acid is a 2'"'"'-deoxyribonucleic acid (DNA).

23. The method of claim 21, wherein the nucleic acid is a ribonucleic acid (RNA).

24. The method of claim 21, wherein the exonuclease is selected from the group consisting of snake venom phosphodiesterase, spleen phosphodiesterase, Bal-31 nuclease, E. coli exonuclease I, E. coli exonuclease VII, Mung Bean Nuclease, S1 Nuclease, an exonuclease activity of E. coli DNA polymerase I, an exonuclease activity of the Klenow fragment of DNA polymerase I, an exonuclease activity of T4 DNA polymerase, an exonuclease activity of T7 DNA polymerase, an exonuclease activity of Taq DNA polymerase, E. coli exonuclease III, λ

exonuclease, an exonuclease activity of Pyrococcus species GB-D DNA polymerase and an exonuclease activity of Thermococcus litoralis DNA polymerase.

25. The method of claim 21, wherein the exonuclease is immobilized by covalent attachment to a solid support, entrapment within a gel matrix, or contained in a reactor with a semipermeable membrane.

26. The method of claim 25, wherein the solid support is a capillary and the exonuclease activity is covalently attached to an inner wall of the capillary.

27. The method of claim 25, wherein the solid support is selected from the group consisting of glass beads, cellulose beads, polystyrene beads, epichlorohydrin-cross-linked dextran beads, polyacrylamide beads and agarose beads.

28. The method of claim 25, wherein the solid support is a flat membrane.

29. The method of claim 21, wherein the nucleic acid is immobilized by covalent attachment to a solid support and the exonuclease is in a solution and is contacted with the immobilized nucleic acid.

30. The method of claim 29, wherein the solid support is a capillary and the nucleic acid is covalently attached to an inner wall of the capillary.

31. The method of claim 29, wherein the solid support is selected from the group consisting of glass beads, cellulose beads, polystyrene beads, epichlorohydrin-cross-linked dextran beads, polyacrylamide beads and agarose beads.

32. The method of claim 29, wherein the solid support is a flat membrane.

33. The method of claim 21, wherein the nucleic acid comprises mass-modified nucleotides.

34. The method of claim 33, wherein the mass-modified nucleotides modulate the rate of the exonuclease activity.

35. The method of claim 21, wherein the multiple sets of nested nucleic acid fragments are mass-modified subsequent to exonuclease release and prior to mass spectrometric identification.

36. The method of claim 35, wherein the multiple sets of nested nucleic acid fragments are mass-modified by contact with an alkaline phosphatase.

37. The method of claim 29, wherein the nucleic acid further comprises a linking group (L) for covalently attaching the nucleic acid to the solid support.

38. The method of claim 37, wherein the solid support further comprises a splint oligonucleotide and the linking group (L) comprises a nucleotide sequence able to anneal to the splint oligonucleotide and be covalently attached to the solid support by action of a ligase.

39. The method of claim 21, wherein the mass spectrometry format used in step (iii) is selected from the group consisting of fast atomic bombardment (FAB), plasma desorption (PD), thermospray (TS), electrospray (ES) and matrix assisted laser desorption (MALDI).

40. The method of claim 21, wherein the mass analyzer used in step (iii) is a time-of-flight (TOF) configuration or a quadrapole.

41. A method of nucleic acid sequencing, comprising the steps of:

(a) obtaining a target nucleic acid to be sequenced wherein the target nucleic acid sequence is flanked by cleavable sites at both ends and wherein the plus and the minus strand of the target nucleic acid are distinguishable from each other by differential mass-modification;

(b) cleaving the target nucleic acid at the flanking cleavable sites;

(c) denaturing the cleaved target nucleic acid to generate single-stranded plus and minus strands;

(d) simultaneously cleaving the denatured plus and minus strands from a first end to a second end with an exonuclease to sequentially release individual nucleotides, wherein the individual nucleotides derived from the plus strand are mass-differentiated from the individual nucleotides derived from the minus strand;

(e) identifying each of the sequentially released nucleotides produced in step (d) by mass spectrometry; and

(f) determining the sequence of the target nucleic acid from the identified nucleotides.

42. The method of claim 41, wherein prior to the exonuclease cleavage of step (d), the plus and the minus strands are immobilized to a solid support.

43. A method of nucleic acid sequencing, comprising the steps of:

(a) obtaining a target nucleic acid to be sequenced wherein the target nucleic acid sequence is flanked by cleavable sites at both ends and wherein the plus and the minus strand of the target nucleic acid are distinguishable from each other by differential mass-modification;

(b) cleaving the target nucleic acid at the flanking cleavable sites;

(c) denaturing the cleaved target nucleic acid to generate single-stranded plus and minus strands;

(d) simultaneously cleaving the denatured plus and minus strands from a first end to a second end with an exonuclease to produce multiple sets of nested nucleic acid fragments, wherein the nested nucleic acid fragments derived from the plus strand are mass-differentiated from the nested nucleic acid fragments derived from the minus strand;

(e) identifying each of the nested nucleic acid fragments produced in step (d) by mass spectrometry; and

(f) determining the sequence of the target nucleic acid from the identified nested nucleic acid fragments.

44. The method of claim 43, wherein prior to the exonuclease cleavage of step (d), the plus and the minus strands are immobilized to a solid support.